Public Release: 

Major bone meeting in Abu Dhabi to include focus on management of diabetic patients

IOF 3rd Middle East & Africa Osteoporosis Meeting will feature a workshop on bone disease and diabetes, 2 chronic health issues that have increased dramatically in the region

International Osteoporosis Foundation

Nyon, Switzerland / Abu-Dhabi, UAE - July 27, 2015 With a growing senior population and an increase in unhealthy lifestyles, the prevalence of osteoporosis and Type 2 Diabetes Mellitus is soaring in the Middle East and North African region. In response to the dramatic increase in these diseases within the region the International Osteoporosis Foundation (IOF), in cooperation with the Emirates Osteoporosis Society (EOS), will be holding the 3rd Middle East & Africa Osteoporosis Meeting from December 5-7, 2015 in Abu Dhabi

Complete information at

Osteoporosis already has a serious impact on the region, and as a result it is facing the highest proportional increase in hip fracture rates in the world: rates are projected to quadruple by 2050 in some countries. Older people who suffer hip fractures are often affected by long-term disability that results in loss of independence and higher risk of death. Mortality rates after hip fracture may be 2-2.5 fold higher in certain populations within the region when compared to Western populations where rates are between 25-35 per cent.

Diabetes (type 2) is another widespread chronic disease which has an enormous impact in the Middle East. Close to one in 10 adults in the region has diabetes and cases are rising rapidly. Without lifestyle changes, it is estimated that a quarter of the Middle East's population will be affected by 2035 (1).

Professor Serge Ferrari, Professor of Medicine at the Service of Bone Diseases, Geneva University Hospital, Switzerland and Scientific Programme Committee Co-Chair said, "Diabetics are now recognized as being at increased risk of fracture, posing a challenge for doctors who treat these patients. Through a dedicated workshop to be held prior to the start of the Meeting, we hope to raise awareness and increase knowledge of the diagnosis and management of bone disease in diabetic patients." The Workshop will address key issues including risk assessment, impact of new diabetes therapies, and osteoporosis management in diabetic patients. It will be co-chaired by Prof. Maha Taysir Barakat, Director General of the Abu Dhabi Health Authority.

Expected to be the region's largest event in the musculoskeletal field, the Meeting will present the latest research by investigators from the region and around the world. More than 60 sessions, including educational lectures and workshops will increase knowledge of the latest advances in the diagnosis and management of bone disease, including in diabetic patients.

Plenary topics and speakers include:

  • Fracture Prediction (JA Kanis) & Fracture Healing (SA Majeed)
  • Vitamin D During the Lifecourse (I Zakraoui, C Cooper, G El Hajj Fuleihan)
  • Who is at Risk and Who to treat? (M Al-Maini, T De Villiers, M Alshaker)
  • Treat to Target (S Ferrari, J-Y Reginster)
  • Challenges with Osteoporosis Therapy (A Khan, H Badsha)
  • New Treatments, incl. sarcopenia (JY Reginster, R Rizzoli)

In addition there will be 10 Meet-the-Expert sessions, two workshops and a special session during which challenging cases can be discussed with the experts.

A special feature of the Meeting includes awards and a unique half-day mentoring programme for selected young investigators from the Middle East who have submitted outstanding abstracts. The aim is to support the development of high quality research in bone and related musculoskeletal disease in the region.

Dr Abdulrahim Al Suhaili, President of EOS and Meeting Co-Chair stressed the importance of the upcoming event as a key research and educational forum for doctors in the region. He stated, "As a disease of increasing relevance, osteoporosis is not adequately addressed during medical training in most countries. For this reason, I encourage all health professionals who deal with osteoporotic patients to learn the latest management techniques by joining us in Abu Dhabi."

The 3rd Middle East & Africa Osteoporosis Meeting is officially endorsed by the Abu Dhabi Health Services (SEHA) and HAAD.

Abstracts, to be published in the journal Osteoporosis International, are accepted until the deadline of August 14, 2015.

For further information, to submit abstracts and to register, visit


Notes to Editors:

About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 200 patient, medical and research societies, work together to make bone, joint and muscle health a worldwide heath care priority.;;

IOF Regionals 3rd Middle East & Africa Osteoporosis Meeting
Abu Dhabi National Exhibitions Center (ADNEC), Abu Dhabi, UAE
December 5-7, 2015

(1) International Diabetes Federation Atlas:

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.